Real world data (RWD) and RWE refer to any relevant patient-level data not collected through a typical, most often randomized, clinical trial (RCT). Clinical trials are usually designed to prove whether a medicine or treatment works under specific conditions and as such have a large number of inclusion and exclusion criteria. This limits the number of patients eligible for the clinical trial and the generalizability of the trial’s results to the other patients with the disease of interest.
RWE adds perspective to RCT results by offering a granular view of the patient journey and treatment experience in the real world. These observations can be gathered from a variety of non-interventional sources, including data from routine hospital or doctor visits, patient registries, claims reports, connected devices, prescription data, observational studies, and other primary and secondary patient-level data.
IQVIA APAC Real World Solutions (RWS) team is the proven partner for the right RWE to meet stakeholder needs throughout the end-to-end product life cycle, from clinical development to launch and post-launch stages.
We are a one-stop RWS provider, with 4 key offerings supported by multiple study approaches. Each study approach has its respective implications and considerations such as timeline, data availability and country-specific factors. Having housed all solutions under one umbrella, we are able to achieve innovation and synergy across approaches, offering clients with the optimal study design to answer your key research questions. Reach out to our RWS experts to help you identify the best approach to answer your key research questions.
conducted in the last five years across Asia Pacific
enrolled across 7,000+ sites in the last five years throughout Asia Pacific
across multi-countries in Asia Pacific in the last five years
including journal and academic conference presentations in the last five years
across multi-countries in Asia Pacific in the last three years
based on secondary database research including journal and academic conference presentations in the last three years
